Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Utility and Safety of 30% Nitrous Oxide Inhalation Sedation Using Nasal High Flow
jRCTs072240042Recruiting
- Sponsor
- Fisher & Paykel Healthcare
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of nitrous oxide in Dental anxiety (2 arms), sponsored by Fisher & Paykel Healthcare. Primary endpoints: Presence or absence of nausea and vomiting and Presence or absence of pain during periodontal pocket examination. Started Jul 2024; status: recruiting.
02
Drugs
nitrous oxide
03
Conditions
Dental anxiety
Beyond the preview
Go deeper on jRCTs072240042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs072240042.